According to Zacks, “Viveve Medical, Inc. is a medical device company focused on technologies for the cardiac and vascular markets. The Company’s lead product, RenalGuard (R), is designed to remove contrast dyes that are known to be toxic to the kidneys. Viveve Medical Inc., formerly known as PLC Systems Inc., is headquartered in Milford, Massachusetts. “
Viveve Medical stock traded up $0.14 during mid-day trading on Thursday, reaching $2.28. 468,862 shares of the stock traded hands, compared to its average volume of 922,432. The company has a quick ratio of 9.50, a current ratio of 10.40 and a debt-to-equity ratio of 0.19. Viveve Medical has a 12-month low of $2.07 and a 12-month high of $6.78. The business’s 50-day moving average is $2.41 and its 200-day moving average is $2.64.
Institutional investors and hedge funds have recently modified their holdings of the business. Jane Street Group LLC purchased a new stake in Viveve Medical in the first quarter worth about $53,000. Virtu Financial LLC purchased a new stake in Viveve Medical in the first quarter worth about $132,000. Geode Capital Management LLC purchased a new stake in Viveve Medical in the first quarter worth about $67,000. Citadel Advisors LLC purchased a new stake in Viveve Medical in the first quarter worth about $90,000. Finally, Goldman Sachs Group Inc. purchased a new stake in Viveve Medical in the first quarter worth about $53,000. Institutional investors and hedge funds own 6.45% of the company’s stock.
About Viveve Medical
Viveve Medical, Inc engages in the design, development, manufacture, and marketing of platform medical technology. It offers cryogen-cooled monopolar radio frequency technology, which delivered through a radiofrequency generator, hand piece and treatment tip. The Viveve system is a non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence.
See Also: Trade War
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.